ID   BL-72
AC   CVCL_C157
SY   BL72; BL 72; BL 072; IARC/BL72; IARC/BL 72; IARC-BL72; IARC BL72; IARC BL 72
DR   cancercelllines; CVCL_C157
DR   Cosmic; 931114
DR   Cosmic; 2804860
DR   Wikidata; Q54797246
RX   PubMed=2985508;
RX   PubMed=3037521;
RX   PubMed=3905596;
RX   PubMed=3934070;
RX   PubMed=6592381;
RX   PubMed=8108117;
RX   PubMed=9473234;
RX   PubMed=11793449;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Algerian.
CC   HLA typing: A*11,28; B*27,45 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; 7553; MYC; Simple; p.Thr73Ile (c.218C>T); ClinVar=VCV000376300; Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IV24 ! IARC-307
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
RX   PubMed=2985508; DOI=10.1002/ijc.2910350404;
RA   Rowe M., Rooney C.M., Rickinson A.B., Lenoir G.M., Rupani H.,
RA   Moss D.J., Stein H., Epstein M.A.;
RT   "Distinctions between endemic and sporadic forms of Epstein-Barr
RT   virus-positive Burkitt's lymphoma.";
RL   Int. J. Cancer 35:435-441(1985).
//
RX   PubMed=3037521; DOI=10.1073/pnas.84.13.4567;
RA   Masucci M.G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E.,
RA   Klein G.;
RT   "Down-regulation of class I HLA antigens and of the Epstein-Barr
RT   virus-encoded latent membrane protein in Burkitt lymphoma lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4567-4571(1987).
//
RX   PubMed=3905596;
RA   Favrot M.-C., Philip I., Philip T., Cabrillat H., Pinatel C.,
RA   Dore J.-F., Lenoir G.M.;
RT   "Immunophenotypic classification of 28 Burkitt cell lines with
RT   monoclonal antibodies and reagent selection for bone-marrow purging.";
RL   IARC Sci. Publ. 60:447-452(1985).
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6592381; DOI=10.1093/jnci/73.4.841;
RA   Favrot M.-C., Philip I., Philip T., Portoukalian J., Dore J.-F.,
RA   Lenoir G.M.;
RT   "Distinct reactivity of Burkitt's lymphoma cell lines with eight
RT   monoclonal antibodies correlated with the ethnic origin.";
RL   J. Natl. Cancer Inst. 73:841-847(1984).
//
RX   PubMed=8108117;
RA   Albert T., Urlbauer B., Kohlhuber F., Hammersen B., Eick D.;
RT   "Ongoing mutations in the N-terminal domain of c-Myc affect
RT   transactivation in Burkitt's lymphoma cell lines.";
RL   Oncogene 9:759-763(1994).
//
RX   PubMed=9473234; DOI=10.1182/blood.V91.5.1680;
RA   Klangby U., Okan I., Magnusson K.P., Wendland M., Lind P., Wiman K.G.;
RT   "p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a
RT   mRNA and protein expression in Burkitt's lymphoma.";
RL   Blood 91:1680-1687(1998).
//
RX   PubMed=11793449; DOI=10.1002/gcc.10022;
RA   Sobol H., Benziane A., Kerangueven F., Yin L., Noguchi T., Pauly S.,
RA   Eisinger F., Longy M., Romeo G., Lenoir G.M., Birnbaum D.;
RT   "Genome-wide search for loss of heterozygosity in Burkitt lymphoma
RT   cell lines.";
RL   Genes Chromosomes Cancer 33:217-224(2002).
//